Zaenker Stephan, Schweyer Stefan, Hasenkamp Justin, Truemper Lorenz, Wulf Gerald
Department of Haematology/Oncology, University Medicine Goettingen, Robert-Koch-Street 40, 37075 Goettingen, Germany.
Case Rep Hematol. 2011;2011:692982. doi: 10.1155/2011/692982. Epub 2011 Sep 5.
Granulocytic sarcoma (GS) represents a rare type of extramedullar manifestation from the acute myeloid leukaemia (AML). We report the case of a patient with recurrences of AML M4eo leukaemia in the uterus and the small intestine at 3 and 5 years, respectively, after matched related peripheral blood stem cell transplantation (PBSCT). The patient underwent the withdrawal of immunosuppression, hysterectomy, and local irradiation at first relapse, as well as systemic chemotherapy and donor lymphocyte infusions at second recurrence, inducing a second and third complete remission, respectively. At year six after transplantation, the patient experienced disease progression by meningeosis leukaemia to which she succumbed despite intrathecal chemotherapy. Following allogeneic stem cell transplantation, awareness for atypical manifestations of granulocytic sarcoma appears prudent, the cellular immunotherapy should aim at immunological disease control.
粒细胞肉瘤(GS)是急性髓系白血病(AML)一种罕见的髓外表现形式。我们报告了1例患者,在接受匹配的亲缘外周血干细胞移植(PBSCT)后3年和5年,分别于子宫和小肠复发AML M4eo白血病。患者在首次复发时接受了免疫抑制撤除、子宫切除术和局部放疗,第二次复发时接受了全身化疗和供体淋巴细胞输注,分别诱导了第二次和第三次完全缓解。移植后第6年,患者因脑膜白血病出现疾病进展,尽管接受了鞘内化疗仍死亡。异基因干细胞移植后,对粒细胞肉瘤的非典型表现保持警惕似乎是明智的,细胞免疫治疗应旨在实现免疫性疾病控制。